[The new approval procedure for clinical trials of medicinal products in the European Union-challenges for the pharmaceutical industry in Germany].
- DOI
- 10.1007/s00103-022-03625-9
- Published
- 2023 Jan
- Container
- Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00103-022-03625-9,
title = {[The new approval procedure for clinical trials of medicinal products in the European Union-challenges for the pharmaceutical industry in Germany].},
author = {Henn DK and Ruppert T},
year = {2023},
journal = {Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz},
doi = {10.1007/s00103-022-03625-9},
url = {https://doi.org/10.1007/s00103-022-03625-9}
}RIS
TY - JOUR TI - [The new approval procedure for clinical trials of medicinal products in the European Union-challenges for the pharmaceutical industry in Germany]. AU - Henn DK AU - Ruppert T PY - 2023 JO - Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz DO - 10.1007/s00103-022-03625-9 UR - https://doi.org/10.1007/s00103-022-03625-9 ER -
APA
DK, H., & T, R. (2023). [The new approval procedure for clinical trials of medicinal products in the European Union-challenges for the pharmaceutical industry in Germany].. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. https://doi.org/10.1007/s00103-022-03625-9
Source records
- pubmed · retrieved 2026-09-27T12:02:24.163Z